Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for
Por um escritor misterioso
Descrição
We identified a total of 14 studies with a low or medium risk of bias for use in our main network meta-analyses (NWMA) comparing the efficacy of drug therapies for early rheumatoid arthritis. Those findings are presented in our main report.
Psych, Free Full-Text
Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 - ScienceDirect
Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf
Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis - ScienceDirect
Sensitivity Analyses for Network Meta-Analyses - Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update - NCBI Bookshelf
Frontiers Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
Chapter 12 Network Meta-Analysis
First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis - ScienceDirect
Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses
Chapter 10: Analysing data and undertaking meta-analyses
Introduction to Meta-Analysis in Stata
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate